<乌鸦传媒>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<乌鸦传媒>Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patients Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
<乌鸦传媒>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒>Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA Swedish study expands range of airborne toxics associated with rheumatic disease Dec 06, 2022
<乌鸦传媒>Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs Benefit seen with conventional DMARDs as well as biologics Dec 02, 2022
<乌鸦传媒>Common Treatments for Knee Osteoarthritis May Be Harmful Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
<乌鸦传媒>Study: New Moms Need Not Worry About Enbrel in Breast Milk Present in small amounts, but infants apparently unaffected in small sample Nov 28, 2022
<乌鸦传媒>Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
<乌鸦传媒>Two Surgery Types Yield Similar Results in Advanced Ankle Osteoarthritis Similar clinical scores with either total ankle replacement or fusion surgery, trial shows Nov 14, 2022
<乌鸦传媒>Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
<乌鸦传媒>For Better COVID Vax Response in Rheumatology Patients, Hold the MMF Longer Small study suggests at least a 10-day holiday Nov 14, 2022
<乌鸦传媒>Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
<乌鸦传媒>Safer Alternative to Cyclophosphamide at Hand for ILD? Drug targeting B cells as effective as broad-spectrum immunosuppressant in lung disease Nov 14, 2022
<乌鸦传媒>Novel BTK Inhibitor Looks Good for Sjogren's Syndrome Phase II data show good efficacy by objective measures, even with strong placebo effect Nov 13, 2022
<乌鸦传媒>ANCA-Associated Vasculitis: Novel Biologic Shows Promise for Replacing Steroids Small trial demonstrates big cut in steroid-linked adverse effects Nov 13, 2022
<乌鸦传媒>Twelve-Month Data Back Pegloticase-Methotrexate Gout Combo More support for add-on methotrexate to maintain protein drug's efficacy Nov 13, 2022
<乌鸦传媒>Want a Few Weeks of Knee Pain Relief? Try This Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
<乌鸦传媒>Sjogren's Responds to Cytokine Treatment, Early Data Show Phase II trial signals possible breakthrough for hard-to-treat illness Nov 10, 2022
<乌鸦传媒>Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
<乌鸦传媒>New ACR/EULAR Guideline Expands RA Remission Definition Axial spondyloarthritis guidance also gets an update Oct 25, 2022
<乌鸦传媒>Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
<乌鸦传媒>Notes From Underground: Miners Face Increased Risk of Rheumatoid Arthritis Silica exposure seen responsible Oct 17, 2022
<乌鸦传媒>What Caused Left-Sided Hearing Loss in This 65-Year-Old Man? Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear Oct 03, 2022
<乌鸦传媒>Have We Been Overcautious With TNF Inhibitors in Pregnancy? Study of IBD patients finds no basis for common practice Sep 26, 2022
<乌鸦传媒>Is PMR the Next Indication for Tocilizumab? Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
<乌鸦传媒>Data Now Out for Pegloticase-MTX Combo Gout Treatment Journal publication supports recent label change Sep 16, 2022
<乌鸦传媒>Is Cancer Therapy Also a Lupus Cure? Patients in pilot study show months-long complete remission Sep 15, 2022
<乌鸦传媒>Confirmed: Gout Comes With Increased Heart Risk But associated conditions (like obesity) still play largest role Sep 13, 2022
<乌鸦传媒>Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
<乌鸦传媒>Good News, Bad News for Global Hip Fracture Rates Incidence has declined, but burden will increase as older population grows Sep 10, 2022
<乌鸦传媒>Mixed Results for Novel Lupus Drug in Mid-Stage Trial Developer of litifilimab, an anti-BDCA2 antibody, presses ahead despite phase II hiccups Sep 07, 2022
<乌鸦传媒>Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
<乌鸦传媒>Xarelto Risky in Rheumatic Heart Disease Ischemic event prevention didn't pan out in INVICTUS trial Aug 28, 2022
<乌鸦传媒>Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis But is Russian backing a problem for U.S. approval? Aug 24, 2022
<乌鸦传媒>Do We Need to Worry About Low Serum Urate? Study may have found answer to long-standing question Aug 19, 2022
<乌鸦传媒>Organ Damage in Lupus: Some Ethnicities Bear More Burden Than Others Results from California cohort mirror epidemiology of lupus itself Aug 16, 2022
<乌鸦传媒>Once the 'Disease of Kings,' Gout Now Reigns Through Poverty, Disparity National data outlines factors behind racial and sex-based disparities Aug 15, 2022
<乌鸦传媒>Study: Flares in Pustular Psoriasis Often Undertreated Drug firm hopes to bring new specific treatment to market Aug 10, 2022
